The U.S. Food and Drug Administration (FDA) has cleared the VistaScan mobile ultrasound platform from startup software device firm Emagine Solutions Technology.
VistaScan transforms clinicians' cellphones or tablets into portable ultrasound devices and uses ultrasound probes that interface with the software, the company said. VistaScan features Emagine's Dynamic Precise Point measuring system, which allows users to make measurements on the ultrasound image.
